Tumor Necrosis Factor Blocker [EPC]

999331 reported adverse events

Drugs of this class: ADALIMUMAB-BWWD ADALIMUMAB-ADAZ ADALIMUMAB-ATTO INFLIXIMAB ADALIMUMAB-AQVH GOLIMUMAB CERTOLIZUMAB PEGOL ETANERCEPT INFLIXIMAB-AXXQ INFLIXIMAB-DYYB

These side effects are most commonly reported by patients taking drugs of the Tumor Necrosis Factor Blocker [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 118444
1 OFF LABEL USE 81282
2 ARTHRALGIA 67848
3 RHEUMATOID ARTHRITIS 62163
4 PAIN 61979
5 INJECTION SITE PAIN 61024
6 FATIGUE 48762
7 CONDITION AGGRAVATED 46284
8 INJECTION SITE ERYTHEMA 42491
9 HEADACHE 38651
See all common reactions for Tumor Necrosis Factor Blocker [EPC]

Drugs of the Tumor Necrosis Factor Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 6357 0.8864
1 RHEUMATOID FACTOR POSITIVE 4933 0.8532
2 SWOLLEN JOINT COUNT INCREASED 2608 0.8170
3 RHEUMATIC FEVER 3633 0.8142
4 PEMPHIGUS 9785 0.7819
5 C-REACTIVE PROTEIN ABNORMAL 4896 0.7625
6 HAND DEFORMITY 9759 0.7433
7 SYNOVITIS 13187 0.7306
8 DUODENAL ULCER PERFORATION 5336 0.7168
9 FACET JOINT SYNDROME 2256 0.6922
See all enriched reactions for Tumor Necrosis Factor Blocker [EPC]